JP2795452B2 - Interface for iontophoresis - Google Patents

Interface for iontophoresis

Info

Publication number
JP2795452B2
JP2795452B2 JP5492589A JP5492589A JP2795452B2 JP 2795452 B2 JP2795452 B2 JP 2795452B2 JP 5492589 A JP5492589 A JP 5492589A JP 5492589 A JP5492589 A JP 5492589A JP 2795452 B2 JP2795452 B2 JP 2795452B2
Authority
JP
Japan
Prior art keywords
layer
porous body
water
drug
interface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP5492589A
Other languages
Japanese (ja)
Other versions
JPH02234774A (en
Inventor
敬一郎 岡部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP5492589A priority Critical patent/JP2795452B2/en
Publication of JPH02234774A publication Critical patent/JPH02234774A/en
Application granted granted Critical
Publication of JP2795452B2 publication Critical patent/JP2795452B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Electrotherapy Devices (AREA)

Description

【発明の詳細な説明】 本発明はイオントフォレーゼ用のインタフェース(皮
膚当接体)に関する。
The present invention relates to an interface (skin abutment) for iontophoresis.

イオントフォレーシスに於けるインタフェースは、薬
液を保持する為のリザーバと電流分散用の電極とを組み
合わせた構造を有する。
The interface in iontophoresis has a structure in which a reservoir for holding a chemical solution and an electrode for current distribution are combined.

このリザーバの構造は、薬剤を生体皮膚界面迄、経時
的に所定量を確実に到達せしめるものでなければならな
いが、リザーバ自体が立体的であり、しかも水を介する
為、薬物の希釈化あるいは水分の蒸散が生じる等、未だ
充分な構造が提案されるに至っていない。
The structure of the reservoir must ensure that the drug reaches a predetermined amount over time to the interface with the skin of the living body, but since the reservoir itself is three-dimensional and passes through water, it is necessary to dilute the drug or remove water. However, a sufficient structure has not yet been proposed.

上記に鑑み本発明は、イオントフォレーシスに適し
た、即ち正確且つ安全な投薬を行ない得る構造を有する
インタフェースを提供することを目的とする。
In view of the above, an object of the present invention is to provide an interface having a structure suitable for iontophoresis, that is, a structure capable of performing accurate and safe medication.

本発明の特徴は次の通りである。 The features of the present invention are as follows.

本発明は、主にセラミックス製等の多孔体に薬物を含
有した薬物層(硬質性多孔質層)と、水を保持してなる
水補給リザーバ層と、これら薬物層と水補給リザーバ層
との間にセラミックス多孔体を介することにより、この
セラミックス多孔体が通電時すなわち投薬時に於いて、
電気浸透効果によりリザーバの水を薬物層に供給すると
いう機能を行なわせしめるものである。
The present invention mainly relates to a drug layer (hard porous layer) containing a drug in a porous body made of ceramics or the like, a water supply reservoir layer holding water, and a water supply reservoir layer formed of the drug layer and the water supply reservoir layer. By passing the ceramic porous body in between, this ceramic porous body is energized, that is, at the time of medication,
The function of supplying the water of the reservoir to the drug layer by the electroosmotic effect is performed.

電気浸透とは、毛細管又は多孔性構造をなす物質によ
り液を2室に分け、両液に電極を入れて直流電圧をかけ
ると液体が移動する現象のことである。この液体の移動
方向は、液体と物質との間のξ−電位の符号によって決
まる。
Electroosmosis is a phenomenon in which a liquid is divided into two chambers by a substance having a capillary structure or a porous structure, and an electrode is placed in both the liquids and a DC voltage is applied, whereby the liquid moves. The direction of movement of the liquid is determined by the sign of the ξ-potential between the liquid and the substance.

従って、薬物層が乾燥状態であっても、投薬時に於い
ては常に含水状態を形成するものである。
Therefore, even when the drug layer is in a dry state, it always forms a water-containing state during administration.

又、本発明にあっては、セラミックス多孔体が半透過
性を有する。
In the present invention, the ceramic porous body has semi-permeability.

従って、水補給リザーバ層から薬物層への通水は行な
うが、高薬物濃度維持のため、薬物層から水補給リザー
バ層への薬物、雑菌の浸出を防ぐという機能を行なわせ
しめるものである。
Therefore, although water flows from the water supply reservoir layer to the drug layer, the function of preventing the leaching of drugs and various bacteria from the drug layer to the water supply reservoir layer to maintain a high drug concentration is performed.

薬物層を形成する多孔体は、素焼、アルミナ、ジルコ
ニア等のセラミックス製多孔体又は合成樹脂材等が例示
される。平均孔径は一般には数μm〜数百μmが良好で
あり、気孔率は通常30〜90%程度が好ましい。尚、孔
径、気孔率共、適応皮膚の汗腺の数、使用薬物の用量等
に応じ適宜選択され、特に限定されない。
Examples of the porous body forming the drug layer include unfired ceramics, ceramic porous bodies such as alumina and zirconia, and synthetic resin materials. Generally, the average pore size is preferably several μm to several hundred μm, and the porosity is usually preferably about 30 to 90%. The pore size and porosity are both selected as appropriate according to the number of sweat glands in the applicable skin, the dose of the drug used, and are not particularly limited.

尚、セラミック材をレーザ加工して毛細管構造体とし
たものも好適に使用され得る。又、これらの材の厚さは
特に限定されないが、通常0.1mm〜10mm程度がよい。
It is to be noted that a ceramic material formed into a capillary structure by laser processing can also be suitably used. Further, the thickness of these materials is not particularly limited, but is usually preferably about 0.1 mm to 10 mm.

尚、これら界面形成手段は、好ましくは硬質材料が使
用されるが、場合によっては(即ち、毛細管等が非変形
性であれば)柔軟フィル乃至シート材でもよい。
In addition, although a hard material is preferably used for these interface forming means, a soft fill or sheet material may be used in some cases (that is, if the capillary or the like is non-deformable).

水分補給用リザーバ層は、容器構造、綿、PVAスポン
ジ、セルローストリアセテート等の水分貯蔵性繊維に含
浸させたもの、あるいは水を保持した膨潤ゲル等が例示
される。又、必要に応じて周囲を硬質性樹脂で形成した
カップで覆い、外部への蒸散を防ぐ構造も取り得る。
The reservoir layer for water replenishment is exemplified by a container structure, one impregnated with water storage fibers such as cotton, PVA sponge, cellulose triacetate, or a swollen gel holding water. If necessary, a structure in which the periphery is covered with a cup formed of a hard resin to prevent evaporation to the outside can be adopted.

セラミックス多孔体は、素焼、アルミナ、ジルコニア
等のセラミックス製多孔体であり、平均孔径は一般には
十分の数μm〜数百μmが良好である(例えば0.40μm
±0.10)。気孔率は通常30〜90%程度が好ましい。
The ceramic porous body is a ceramic porous body made of unfired, alumina, zirconia, or the like, and the average pore size is generally good enough to be several μm to several hundred μm (for example, 0.40 μm).
± 0.10). The porosity is usually preferably about 30 to 90%.

尚、孔径、気孔率共、適応皮膚の汗腺の数、使用薬物
の用量等に応じ適宜選択され、特に限定されない。
The pore size and porosity are both selected as appropriate according to the number of sweat glands in the applicable skin, the dose of the drug used, and are not particularly limited.

又、本発明で示す水は、これに限るものではなく、例
えば塩化ナトリウム等の電解質液であってもよい。
The water shown in the present invention is not limited to this, and may be an electrolyte solution such as sodium chloride.

次に、本発明の実施例を図面を参照して詳細に説明す
る。
Next, embodiments of the present invention will be described in detail with reference to the drawings.

第1図に於いて、1は水分補給用リザーバ層であり、
上述した如く多孔質体に水乃至電解質液を含浸させたも
の、あるいは上述した膨潤ゲル状のもの等である。
In FIG. 1, 1 is a reservoir layer for hydration,
As described above, a porous body impregnated with water or an electrolyte solution, or a swollen gel-like body described above is used.

2はセラミックス多孔体であり、3は薬物を含有せし
めた硬質性多孔体である。水分補給用リザーバ層1、セ
ラミックス多孔体2及び硬質性多孔体3は、図示されて
いる如く積層され、水分補給用リザーバ層1上面には、
導電性ゴム、導電性ポリマー、カーボンフィルム、アル
ミ箔他、金属箔よりなる電極4が積層されている。これ
ら積層構造物は、柔軟性支持部材6によって覆われ、支
持固定されている。
Reference numeral 2 denotes a ceramic porous body, and reference numeral 3 denotes a hard porous body containing a drug. The hydration reservoir layer 1, the ceramic porous body 2, and the hard porous body 3 are laminated as shown in the drawing.
An electrode 4 made of a conductive rubber, a conductive polymer, a carbon film, an aluminum foil or a metal foil is laminated. These laminated structures are covered and supported and fixed by the flexible support member 6.

支持部材6は、更に生体皮膚表面01迄延びており、生
体皮膚表面01と接触面には各種貼着剤、接着剤11が付設
されている。
The support member 6 further extends to the living skin surface 01, and various adhesives and adhesives 11 are provided on the contact surface with the living skin surface 01.

次に、他の構造体を第2図に示す。第2図に示す実施
例は、1対の電極及びパワーサプライユニットを備えた
ものを示す。
Next, another structure is shown in FIG. The embodiment shown in FIG. 2 is provided with a pair of electrodes and a power supply unit.

水分補給用リザーバ層1は、硬質性カップ部材5とこ
のカップ部材5の開口部に、セラミックス多孔体2及び
硬質性多孔体3の積層体が装着されることによって密閉
された空間を形成し、この空間に電解質液乃至水が抽入
されてなる。更に、このカップ部材5表面は柔軟性支持
部材6に覆われている。又、カップ部材5の内側上面に
は電極4が装着されている。
The hydration reservoir layer 1 forms a closed space by mounting a rigid cup member 5 and a laminate of the ceramic porous body 2 and the hard porous body 3 at the opening of the cup member 5, An electrolyte solution or water is drawn into this space. Further, the surface of the cup member 5 is covered with a flexible support member 6. The electrode 4 is mounted on the inner upper surface of the cup member 5.

支持部材6は生体皮膚表面迄延び、生体皮膚表面との
接触面には、電極4と同材よりなる対極用電極9が付設
され、この対極用電極9の表面には、更に付着性を有す
る導電性ゲル層7(例:生体用電極に使用されるもの)
が貼着固定されている。
The support member 6 extends to the surface of the living skin, and a counter electrode 9 made of the same material as the electrode 4 is attached to a contact surface with the surface of the living skin, and the surface of the counter electrode 9 has further adhesiveness. Conductive gel layer 7 (eg, used for biological electrodes)
Is attached and fixed.

カップ部材5の上面には、電池及びICを備えた電気出
力を行なうパワーサプライユニット8が装着されてい
る。パワーサプライユニット8と電極4及び対極用電極
9とは導電線によって接続されている(導電線は図示せ
ず)。
On the upper surface of the cup member 5, a power supply unit 8 that includes a battery and an IC and performs electric output is mounted. The power supply unit 8 is connected to the electrode 4 and the counter electrode 9 by conductive wires (conductive wires are not shown).

尚、カップ部材5に水を抽入する為の抽入口は、開閉
機構を有するものが好ましい(例えば特開昭49−77479
号公報に図示されている形状)。
It is preferable that the extraction port for extracting water into the cup member 5 has an opening / closing mechanism (for example, Japanese Patent Laid-Open No.
The shape illustrated in Japanese Patent Publication No.

第2図に示す実施例を使用する場合、導電性ゲル層7
を生体皮膚表面01に貼着すれば、硬質性多孔質層3も生
体皮膚表面01に良好に接触し、電極4及び対極用電極9
間に生体皮膚組織を介して閉回路が得られ、投薬の準備
が完了する。
When the embodiment shown in FIG. 2 is used, the conductive gel layer 7
Is adhered to the living skin surface 01, the hard porous layer 3 is also in good contact with the living skin surface 01, and the electrode 4 and the counter electrode 9
In the meantime, a closed circuit is obtained via the living skin tissue, and preparation for administration is completed.

硬質性多孔質層3に含有される薬液は、その分子量そ
の他諸量に限定されるものではないが、本発明インタフ
ェースは、特に用量が微量にも拘らず、イオントフォレ
ーシスの効率上、可及的高濃度を維持し且つ充分な水の
存在を要する、主としてインスリン等のペプチド系薬物
に有用である。
The chemical solution contained in the hard porous layer 3 is not limited to its molecular weight and other various amounts. However, the interface of the present invention is suitable for the efficiency of iontophoresis, even though the dose is particularly small. It is useful mainly for peptide-based drugs such as insulin, which maintain the highest possible concentrations and require the presence of sufficient water.

鎮咳去痰剤 クロモグリク酸ナトリウム、フマール酸ケトチフェン 気管支拡張剤 フマル酸ホルモテロール 鎮痛剤 塩酸ナルブフィン、乳酸ペンタゾシン、ジクロフェナ
ックナトリウム 強心剤 塩酸ドパミン 精神神経安定剤 ペルフェナジン、フェノチアジン 抗生物質 セフォテタン二ナトリウム、硫酸ジベカシン、硫酸ア
ミカシン、硫酸ネチルマイシン、硫酸シソマイシン 抗悪性腫瘍剤 アドリアマイシン、マイトマイシンC、塩酸ブレオマ
イシン、レンチナン、ピシバニール、硫酸ビンクリスチ
ン、シスプラチン 循環機能改善剤 クエン酸ニカメタート、塩酸メクロフェノキサート、
マレイン酸リスリド、ホパンテン酸カルシウム 痛風治療剤 アロプリノール その他ペプタイド類 LHRH,エンケファリン、エンドルフィン、インターフ
ェロン、インシュリン、カルシトニン、TRH,オキシトシ
ン、リプレシン、バソプレシン、グルカゴン、脳下垂体
ホルモン(HGH,HMG,HCG,酢酸デスモプレシン)、卵胞黄
体ホルモン 以上詳述の如く本発明は、セラミックス多孔体の介在
により、硬質性多孔質層3に含有された薬液が希釈され
ることなく、適当な水分が補給でき、しかも生体表面乃
至外部から浸入する細菌の水補給層への浸入を阻止で
き、長期間正確な投薬を行なえる等の効果を有するもの
である。
Antitussive expectorant sodium cromoglycate, ketotifen fumarate bronchodilator formoterol fumarate analgesic narbuphine hydrochloride, pentazocine lactate, diclofenac sodium cardiotonic agent dopamine hydrochloride psychoneuric stabilizer perphenazine, phenothiazine antibiotic cefotetan disodium sulfate, dibecacin sulfate Netilmycin, sisomicin sulfate Antineoplastic agent Adriamycin, Mitomycin C, Bleomycin hydrochloride, Lentinan, Picibanil, Vincristine sulfate, Cisplatin Circulating function improver Nicametate citrate, Meclofenoxate hydrochloride,
Lisulide maleate, Calcium hopantenate Gout treatment Allopurinol Other peptides LHRH, Enkephalin, Endorphin, Interferon, Insulin, Calcitonin, TRH, Oxytocin, Ripressin, Vasopressin, Glucagon, Pituitary hormone (HGH, HMG, HCG, Desmopressin acetate) As described in detail above, the present invention can provide an appropriate water supply without diluting the drug solution contained in the hard porous layer 3 by interposing the ceramic porous body, and furthermore, the living body surface or the outside. Thus, it is possible to prevent bacteria that intrude from the water supply layer from infiltrating into the water replenishing layer, and to have effects such as performing accurate medication for a long period of time.

【図面の簡単な説明】[Brief description of the drawings]

第1図、第2図は、本発明の実施例を示す図である。 1……水補給リザーバ層、 2……セラミックス多孔体、 3……硬質性多孔体(薬物層)、 4……電極、 6……支持部材、 01……生体皮膚表面。 1 and 2 are views showing an embodiment of the present invention. DESCRIPTION OF SYMBOLS 1 ... Water supply reservoir layer, 2 ... Ceramic porous body, 3 ... Hard porous body (drug layer), 4 ... Electrode, 6 ... Support member, 01 ... Living skin surface.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】水分補給用リザーバ層、セラミックス材よ
りなる硬質性多孔質層及び上記両層間にセラミックス多
孔体を介在せしめたことを特徴とするイオントフォレー
ゼ用インタフェース。
An iontophoresis interface comprising a reservoir layer for water supply, a hard porous layer made of a ceramic material, and a ceramic porous body interposed between the two layers.
JP5492589A 1989-03-09 1989-03-09 Interface for iontophoresis Expired - Fee Related JP2795452B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5492589A JP2795452B2 (en) 1989-03-09 1989-03-09 Interface for iontophoresis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492589A JP2795452B2 (en) 1989-03-09 1989-03-09 Interface for iontophoresis

Publications (2)

Publication Number Publication Date
JPH02234774A JPH02234774A (en) 1990-09-17
JP2795452B2 true JP2795452B2 (en) 1998-09-10

Family

ID=12984195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5492589A Expired - Fee Related JP2795452B2 (en) 1989-03-09 1989-03-09 Interface for iontophoresis

Country Status (1)

Country Link
JP (1) JP2795452B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004402A (en) * 1994-10-06 1999-12-21 Xomed Surgical Products, Inc. Method of cleaning silicon material with a sponge
US6130264A (en) 1994-10-06 2000-10-10 Xomed Surgical Products, Inc. Synthetic sponge and surgical spear comprising synthetic sponge
US6080092A (en) 1994-10-06 2000-06-27 Xomed Surgical Products, Inc. Industrial cleaning sponge
US9757554B2 (en) 2007-08-23 2017-09-12 Bioness Inc. System for transmitting electrical current to a bodily tissue
EP2180918B1 (en) 2007-08-23 2017-07-12 Bioness Inc. Electrodes with a power source and with connectors for coupling to an external stimulator
US8738137B2 (en) 2007-08-23 2014-05-27 Bioness Inc. System for transmitting electrical current to a bodily tissue

Also Published As

Publication number Publication date
JPH02234774A (en) 1990-09-17

Similar Documents

Publication Publication Date Title
JP2542792B2 (en) User-operated iontophoretic device
ES2320892T3 (en) ELECTROTRANSPORT DEVICE THAT HAS A DEPOSIT COVER WITH A FLEXIBLE DRIVING ELEMENT.
FI115609B (en) Iontophoretic dosing device
JP4183909B2 (en) Anhydrous drug reservoir for electrolytic transdermal delivery device
JP4361020B2 (en) Iontophoresis drug delivery system
ES2229672T3 (en) ELECTROCHEMICALLY REACTIVE CATODES FOR ELECTROTRANSPORT DEVICE.
JP2818075B2 (en) Interface for iontophoresis
JP4262410B2 (en) Electrical transmission electrode assembly with low initial resistance
KR960001128B1 (en) Applicator for trans-dermal effect
JPH11239621A (en) Iontophoresis device
CA2026885C (en) Interface for iontophorese
JPH11216192A (en) Controlling membrane for medication by electric transportation
HU225563B1 (en) Transdermal electrotransport device and method for manufacturing same
JP2795452B2 (en) Interface for iontophoresis
EP0586666B2 (en) User activated iontophoretic device
JP2795453B2 (en) Interface for iontophoresis
JP2845509B2 (en) Interface for iontophoresis
JP2792660B2 (en) Interface for iontophoresis
JP2792661B2 (en) Interface for iontophoresis
EP0417290A1 (en) Interface for electric endermism
JP2795466B2 (en) Interface for iontophoresis
JP2845501B2 (en) Interface for iontophoresis
JP2798272B2 (en) Interface for iontophoresis
JPH0616535A (en) Interface for iontophoresis
CN101300044A (en) Handheld apparatus to deliver active agents to biological interfaces

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees